Why We Funded AI Ethics Education for Research Oversight —and Left the Agenda to PRIM&R
As AI becomes part of research workflows, the people responsible for ethical oversight need opportunities to examine its implications together
Universal
Q&A with Advarra’s Senior Director of IRB Services Christy Frey
Christy Frey has spent nearly two decades helping research move forward—ethically, efficiently, and always with people in mind. As senior
Site-Sponsor Consortium
Site-Sponsor Consortium Building shared industry standards through collaboration The Site-Sponsor Consortium is an invitation-only forum that brings together influential leaders
Using Longitudinal Endpoint Data to Anticipate Study Complexity
When it comes to unnecessary protocol complexity, the cracks often show up later. Amendments. Delayed activation. Added site burden. By
Q&A with Advarra’s Senior Coordinator of Client Services Rachel Garrett
Rachel Garrett’s career in clinical research has come full circle. After starting her journey at Schulman IRB in 2008, stepping
ACRO Global Summit
ACRO Global Summit brings together senior regulators and industry leaders from around the world to discuss the evolving regulatory landscape
Why Do Clinical Trial Startup Delays Still Happen Despite More Technology?
Clinical trial study startup has become increasingly technology-enabled, yet sponsors, contract research organizations (CROs), and research sites still face persistent
The Next Generation of CIRBI, the Technology Powering Advarra’s IRB
A note from Lauri Carlile, Chief Research Services Officer: For more than 40 years, Advarra’s institutional review board (IRB) has
Ensuring Operational Feasibility in Next-Generation Oncology Trials
Our webinar discusses key near-term trends and regulations and investigate persistent challenges frequently throwing even the most efficient teams off track. Advarra and industry representatives will dive deeper into achieving critical milestones across study startup, conduct, and close out that every project manager should optimize.
Data Safety Monitoring Boards (DSMBs) in the Era of AI and Adaptive Clinical Trials
Balancing innovation, statistical rigor, and independent oversight in increasingly complex clinical trials Clinical trials are no longer static. Over the
A More Connected Approach to Clinical Trials: Reducing Friction from Study Design Through Conduct
Clinical trials are complex. That’s expected, given accelerated advancements in science and technology. But when that complexity creates friction in
Gene Therapy Is Seen as the Next Big Biologic in Ophthalmology
Over the last 15 to 20 years, monoclonal antibody-based treatments, such as those targeting vascular endothelial growth factor (anti-VEGF), have